Prognostic Biomarkers and AKI: Potential to Enhance the Identification of Post-Operative Patients at Risk of Loss of Renal Function
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Early identification of surgical patients at risk of acute kidney injury (AKI) is crucial. Novel biomarkers show promise for improving AKI detection and guiding postoperative care beyond traditional markers.
Area Of Science
- Nephrology
- Surgical Complications
- Biomarker Discovery
Background
- Acute kidney injury (AKI) frequently complicates surgical procedures, with risk escalating with surgical complexity.
- Multiple perioperative factors contribute to AKI, including hypotension, inflammation, nephrotoxic agents, and ischemia-reperfusion injury.
- Conventional AKI markers (serum creatinine, urine output) are often unreliable in surgical patients due to factors like fluid resuscitation and altered muscle mass.
Purpose Of The Study
- To review the performance of novel biomarkers for AKI detection in surgical settings.
- To discuss the application of these biomarkers in guiding postoperative patient management.
- To highlight the limitations of traditional AKI markers in the perioperative period.
Main Methods
- Systematic review of studies evaluating novel AKI biomarkers.
- Analysis of biomarker performance data in surgical patient cohorts.
- Discussion of clinical utility and implementation strategies for biomarkers.
Main Results
- Novel biomarkers demonstrate potential for earlier and more accurate AKI identification compared to conventional markers.
- Specific biomarkers show varying degrees of efficacy across different surgical contexts.
- Evidence supports the use of biomarkers to personalize postoperative care and potentially mitigate AKI progression.
Conclusions
- Novel biomarkers offer a promising avenue for improving AKI management in surgical patients.
- Further research is needed to validate and standardize biomarker use in clinical practice.
- Integrating biomarker data into clinical decision-making can enhance patient outcomes after surgery.
Keywords:
CCL14 DKK-3 IGFBP-7 KIM-1 NGAL PENK acute kidney injury biomarkers chemokine 14 dickkopf-3 insulin growth factor binding protein-7 and TIMP-2 kidney injury molecule-1 neutrophil gelatinase-associated lipocalin proenkephalin A 119-159 soluble urokinase plasminogen activator receptor suPAR tissue inhibitor of metalloproteinases-2
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
